Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨
On November 16, 2026, Cypherpunk Technologies
Inc. (the “Company”) announced its financial results for the quarter ended September 30, 2026. The full text of the press
release issued by the Company in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information contained herein and in the accompanying
exhibit shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless
of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing. The information
in this Current Report on Form 8-K, including the information set forth under this Item 2.02 and the exhibit hereto, shall not be deemed
to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities
of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended.
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Exhibit 99.1

Cypherpunk Technologies Reports Third Quarter
2026 Financial Results
First quarter of Zcash Mining: 8,967.29 ZEC
Mined in 44 days, representing $9.9 million revenue at approximately $104 cost of mining revenue per ZEC and 95% uptime
Treasury increased to 341,858.75 ZEC, including
October mining results and recent open market purchases, approximately 2.01% of circulating supply
Company to host X Spaces event today, November 16,
2026, at 9:00 a.m. ET
CAMBRIDGE, Mass. – November 16,
2026 – Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), a privacy technology company, today reported financial
results for the third quarter ended September 30, 2026.
“The launch of Cypherpunk Mining in August was
transformative, as it enabled the production of ZEC alongside our purchases and contributes to the security of the Zcash network. In the
first six weeks of operation, our fleet earned 8,967.29 ZEC as a result of an exceptional 95% uptime, all of which was added to our treasury
in a momentous third quarter for the company,” said Douglas E. Onsi, President and Chief Executive Officer of Cypherpunk Technologies.
“As we hold the ZEC we mine, we translated our Zcash flow into $9.9 million in recorded revenue. The average fair value of the mined
ZEC was more than $1,100, while our hosting cost to mine one ZEC was approximately $104.”
“The quarter marked a major milestone
for Cypherpunk, and we are already planning for significant continued growth. We intend to increase our overall hashrate through
additional equipment purchases with the goal of representing approximately 25% of the total Zcash network over time,” said
Will McEvoy, Chief Investment Officer of Cypherpunk. “Cypherpunk Mining is the newest piece of the constellation of privacy
technologies and investments that we are assembling. With 341,858.75 ZEC held, representing 2.01% of the total circulating supply, we
continue to execute on our objective of holding at least 5% of the ZEC supply over time. We also plan to expand our efforts in
privacy technology development and investment more broadly as we head into 2027.”
Cypherpunk Highlights:
Launched Cypherpunk Mining, the world's largest Zcash mining
fleet at launch
| · | On August 17, 2026, Cypherpunk Mining acquired
from Moria Mining, LLC, an affiliate of Winklevoss Treasury Investments, LLC ("WTI"), Bitmain Antminer Z15 Pro Zcash mining
machines, the colocation and hosting agreements under which those machines are installed and operated at three third-party hosting facilities,
and related hosting deposits (the "Mining Asset Acquisition"). The purchase price of $33.33 million was paid through the issuance
to WTI of a pre-funded warrant to purchase 43,290,042 shares of Cypherpunk common stock at an exercise price of $0.001 per share. |
| · | Cypherpunk's mining fleet launched on August 18,
2026, and at the time was the largest Zcash mining operation in the world. Cypherpunk's fleet has a deployed hashrate of approximately
4.2 GSol/s. At the closing of the Mining Asset Acquisition, Cypherpunk's fleet represented approximately 18% of total Zcash network hashrate.
Cypherpunk's mining business is led by Kevin Zhang, its Head of Mining, who joined the Company in August 2026. |
Key operating metrics
| · | Mining revenue was $9.9 million for the three
months ended September 30, 2026, Cypherpunk's first period of mining operations, and reflects 8,967.29 ZEC earned from August 18,
2026 through September 30, 2026, at an average fair value of $1,105.46 per ZEC. |
| · | Fleet operations demonstrated approximately 95%
uptime. |
| · | Total Zcash network
hashrate increased from approximately 23 GSol/s at August 18, 2026 to approximately 32 GSol/s as of November 13, 2026. Cypherpunk's
share of network hashrate represents approximately 13.1% as of November 13, 2026. |
| · | Cost to mine one ZEC, excluding depreciation
of mining equipment, was $104.33, or 9.44% of the production value of one ZEC mined. Cost to mine one ZEC, including depreciation of mining
equipment, was $237.46, or 21.48% of the production value of one ZEC mined. |
Positioning the fleet to grow with the network
| · | To expand the mining fleet, in September 2026,
Cypherpunk Mining entered into a letter of intent with Bitmain Technologies Delaware Limited ("Bitmain") for the purchase of
Bitmain's next-generation Zcash mining machines with a total purchase commitment of up to $30.0 million, of which $6.0 million was paid
as a refundable deposit, with delivery expected in mid-2027. Completion of this transaction would expand Cypherpunk's mining fleet towards
the goal of representing approximately 25% of the overall Zcash network hashrate as that hashrate increases over the next year. |
October mining results of 5,721.35 ZEC
| · | In October 2026, Cypherpunk mined an additional
5,721.35 ZEC, all of which were added to the treasury, and achieved an uptime of approximately 97%. |
ZEC treasury holdings increased to 341,858.75 ZEC
| · | Since the end of the third quarter, Cypherpunk
acquired an additional 3,775.72 ZEC through open market purchases for approximately $3.475 million at an average price of $920.40 per ZEC. |
| · | Including the recent open market purchases
and the October mining results, Cypherpunk holds a total of 341,858.75 ZEC, representing approximately 2.01% of the circulating
supply of ZEC. Cypherpunk's current stated objective is to accumulate holdings representing at least 5% of the circulating supply of
ZEC over time. |
Amanda Fabiano appointed to Board of Directors
| · | In September 2026, Cypherpunk appointed
Amanda Fabiano to its Board of Directors. Fabiano currently serves as Chief Operating Officer of Nakamoto Inc., a publicly listed bitcoin-focused
company, and as an independent director of TeraWulf Inc., a public bitcoin mining company that has expanded into AI and high-performance
computing infrastructure. Previously, she held senior mining and investment roles at Galaxy and Fidelity. |
Leap Therapeutics Subsidiary Highlights:
| · | Following publication of the randomized Phase
2 DeFianCe study in Clinical Cancer Research in August 2026, receipt of Fast Track designation in May 2026, and alignment
with the FDA on the design of a registrational Phase 3 trial in a DKK1-high 2L CRC population, Leap initiated a strategic process to identify
the best path forward for sirexatamab and to secure the resources required to advance the program into Phase 3 development. The process
may include financing the program as an independent entity or a strategic transaction with a pharmaceutical or biotechnology company,
including a partnership, license, collaboration, sale or other business combination. There can be no assurance that the process will result
in any transaction or financing, and the Company has not set a timetable for its conclusion. |
Third Quarter 2026 Financial Results:
Cypherpunk recorded net income of $306.0 million,
or $1.44 per basic share and $1.13 per diluted share, for the three months ended September 30, 2026, compared to a net loss of $3.3
million, or $0.08 per basic and diluted share, for the three months ended September 30, 2025. Cypherpunk's net income for the 2026
period was primarily driven by the non-cash unrealized gain on the embedded derivative, reflecting the increase in the price of ZEC from
$400.09 per ZEC at June 30, 2026 to $1,414.56 per ZEC at September 30, 2026, partially offset by a provision for income taxes
of $27.5 million.
Mining revenue was $9.9 million for the three
months ended September 30, 2026, Cypherpunk's first period of mining operations, and reflects 8,967.29 ZEC earned from August 18,
2026 through September 30, 2026 at an average fair value of $1,105.46 per ZEC. Cypherpunk had no revenue in the three months ended
September 30, 2025. Mining revenue is a non-cash item, as Cypherpunk received ZEC, not cash.
Cost of revenue (excluding depreciation and amortization)
was $0.9 million for the three months ended September 30, 2026 and consisted of hosting costs, including electricity pass-through
charges.
Depreciation expense related to Cypherpunk's mining
equipment was $1.2 million for the three months ended September 30, 2026, representing 44 days of depreciation of the mining machines
that were acquired in the Mining Asset Acquisition on a straight-line basis over an estimated useful life of three (3) years.
Research and development expenses were $0.2 million
for the three months ended September 30, 2026, compared to $1.2 million for the three months ended September 30, 2025. The decrease
of $1.0 million in research and development expenses during the three months ended September 30, 2026 as compared to the same period
in 2025, was primarily due to a decrease in headcount, clinical trial, and manufacturing costs, due to the completion of the Company's
clinical trials in 2025.
General and administrative expenses were $4.9
million for the three months ended September 30, 2026 compared to $1.9 million for the three months ended September 30, 2025.
The increase of $3.0 million in general and administrative expenses during the three months ended September 30, 2026 was primarily
due to a $2.2 million increase in stock-based compensation expense. There was also an increase of $0.4 million in professional fees and
an increase in insurance costs of $0.4 million.
During the three months ended September 30,
2026, Cypherpunk recorded an unrealized gain of $330.8 million on the change in fair value of embedded derivative, reflecting the increase
in the price of ZEC from $400.09 per ZEC at June 30, 2026 to $1,414.56 per ZEC at September 30, 2026.
As of September 30, 2026, Cypherpunk had
cash and cash equivalents of $56.0 million and ZEC treasury holdings categorized as a digital asset receivable valued at $470.1 million.
X Spaces Details:
Cypherpunk Technologies Inc. will host a live
Spaces event on X today, November 16, 2026, at 9:00 a.m. ET to discuss the 3Q 2026 financial results. The X Spaces event will
be available at https://x.com/cypherpunk. A replay will be available on the Investors section of the
Company’s website at www.cypherpunk.com following the event.
About Cypherpunk
Cypherpunk Technologies is a privacy technology
company. The Company's mission is to advance technologies that guarantee privacy for humans on the internet. Cypherpunk pursues this mission
through three primary strategies: mining Zcash through Cypherpunk Mining; accumulating Zcash through open market purchases; and investing
in, acquiring, and building technologies that push the frontier of privacy forward. Additionally, through its subsidiary Leap Therapeutics,
the Company is developing novel therapies for patients with cancer by continuing the development of sirexatamab and FL-501. For more information
about the Company, visit our websites at http://www.cypherpunk.com and http://www.leaptx.com
or view our public filings with the SEC that are available via EDGAR at http://www.sec.gov.
FORWARD-LOOKING STATEMENTS
This press release includes forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. These forward-looking statements generally can be identified by the use of words such as "anticipate,"
"expect," "plan," "could," "may," "will," "believe," "estimate,"
"forecast," "goal," "project," and other words of similar meaning. Forward-looking statements address various
matters including statements relating to the Company's ZEC mining operations, the hashpower represented by the acquired Z15 Pro machines,
the Zcash flow or profitability of the Company's mining operations, the potential purchase of new Zcash mining machines, the comparative
economics or profitability of Zcash mining relative to other digital infrastructure or mining activities, the future hashrate of the Zcash
Network, the Company’s target share of the Zcash network hashrate, the value of the Company's ZEC holdings, the Company's target
percentage ownership of the ZEC supply, the expected future market, price, and liquidity of ZEC, the Company's expected use of Zcash flow
or other capital generated by its mining operations, the potential value of the Company's investment in Zcash Open Development Labs ("ZODL"),
the macro and political conditions surrounding Zcash or digital assets, the Company's plan for value creation and strategic advantages,
market size and growth opportunities, regulatory conditions, competitive position and the interest of other corporations in similar business
strategies, technological and market trends, and future financial condition and performance. Risks and uncertainties of the Company's
strategy include, among others: (a) risks relating to the Company's operations and business, including the performance of the Company's
Zcash mining machines and the highly volatile nature of the price of ZEC; (b) the risk that material changes in the price of ZEC,
such as decreases in price, will result in significant changes to the Company's financial statements, such as unrealized losses on fair
value of ZEC holdings, and reduced net income or increased net loss; (c) the risk that material changes in the hashrate of the Zcash
Network, such as increases in hashrate, will result in significant changes to the Company's financial statements, such as reduced revenue,
reduced gross margins, and reduced net income or increased net loss; (d) the risk that the price of the Company's common stock may
be highly correlated to the price of ZEC; (e) the risk that the Company will fail to realize the anticipated benefits of the ZEC
mining operation or digital asset treasury strategy; (f) risks related to the custody of our ZEC and our reliance on Gemini Space
Station and its affiliates for trading and custody services; (g) changes in business, market, financial, political and regulatory
conditions; (h) risks related to increased competition in the industries in which the Company
does and will operate; (i) risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital
assets generally; (j) risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; (k) risks related
to the Company's dependence on third-party hosting facilities and service providers for its mining operations; and (l) the risk that
the Company does not enter into a definitive agreement to purchase next-generation Zcash mining machines, or that such machines are not
delivered on the expected timetable, at the expected price, or with the expected performance, or at all.
With respect to our biotechnology operations,
important factors that could cause actual results to differ materially from our plans, estimates or expectations could include, but are
not limited to: (i) the DeFianCe study did not meet its prespecified primary endpoint of progression-free survival in the intent-to-treat
population; (ii) the DKK1 biomarker subgroup and interaction analyses were exploratory and may not be replicated in a prospective
clinical trial; (iii) the Company's ability to obtain additional capital to advance sirexatamab on acceptable terms or at all; and
(iv) that risk that the strategic process may not result in any transaction or financing, may be terminated at any time, and any
resulting transaction may not be on terms favorable to the Company or its stockholders.
New risks and uncertainties may emerge from time
to time, and it is not possible to predict all risks and uncertainties. No representations or warranties (expressed or implied) are made
about the accuracy of any such forward-looking statements. The Company may not actually achieve the forecasts disclosed in such forward-looking
statements, and you should not place undue reliance on such forward-looking statements. Such forward-looking statements are subject to
a number of material risks and uncertainties including but not limited to those set forth under the caption "Risk Factors" in
the Company's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the quarter ended September 30,
2026 filed with the SEC, or as may be included in other reports or information we file with the SEC, as well as discussions of potential
risks, uncertainties, and other important factors in its subsequent filings with the SEC. Any forward-looking statement speaks only as
of the date on which it was made. Neither the Company, nor any of its affiliates, advisors or representatives, undertake any obligation
to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except
as required by law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent
to the date hereof.
Cypherpunk™, Cypherpunk Mining™, Cypherpunk
Technologies™, and the Cypherpunk logo™ are all trademarks of Cypherpunk Technologies Inc.
Cypherpunk
Technologies Inc.
Consolidated
Balance Sheets
(in
thousands, except share and per share amounts)
| | |
September 30, | | |
December 31, | |
| | |
2026 | | |
2025 | |
| | |
| (Unaudited) | | |
| | |
| Assets | |
| | | |
| | |
| Current
assets: | |
| | | |
| | |
| Cash
and cash equivalents | |
$ | 55,988 | | |
$ | 14,035 | |
| Digital
assets receivable | |
| 470,146 | | |
| 147,404 | |
| Research
and development incentive receivable | |
| - | | |
| 602 | |
| Prepaid
expenses and other current assets | |
| 308 | | |
| 40 | |
| Total
current assets | |
| 526,442 | | |
| 162,081 | |
| | |
| | | |
| | |
| Property
and equipment, net | |
| 28,811 | | |
| - | |
| Right
of use assets, net | |
| 38 | | |
| 38 | |
| Deferred
costs | |
| 242 | | |
| 401 | |
| Deposits | |
| 6,815 | | |
| 662 | |
| Other
investment | |
| 5,000 | | |
| - | |
| Total
assets | |
$ | 567,348 | | |
$ | 163,182 | |
| | |
| | | |
| | |
| Liabilities
and Stockholders' Equity | |
| | | |
| | |
| Current
liabilities: | |
| | | |
| | |
| Accounts
payable | |
$ | 975 | | |
$ | 1,981 | |
| Accrued
expenses | |
| 1,261 | | |
| 2,067 | |
| Income
tax payable | |
| 111 | | |
| 472 | |
| Lease
liability | |
| 38 | | |
| 38 | |
| Total
current liabilities | |
| 2,385 | | |
| 4,558 | |
| | |
| | | |
| | |
| Non-current
liabilities: | |
| | | |
| | |
| Deferred
tax liability | |
| 29,404 | | |
| 5,118 | |
| Total
liabilities | |
| 31,789 | | |
| 9,676 | |
| | |
| | | |
| | |
| Stockholders'
equity: | |
| | | |
| | |
| Preferred
stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding as of September 30, 2026 and December 31,
2025, respectively | |
| - | | |
| - | |
| Common
stock, $0.001 par value; 490,000,000 shares authorized; 144,102,792 and 83,851,051 shares issued and outstanding as of September 30,
2026 and December 31, 2025, respectively | |
| 144 | | |
| 84 | |
| Stock
subscription receivable | |
| - | | |
| (150 | ) |
| Additional
paid-in capital | |
| 729,813 | | |
| 616,216 | |
| Accumulated
other comprehensive loss | |
| (77 | ) | |
| (95 | ) |
| Accumulated
deficit | |
| (194,321 | ) | |
| (462,549 | ) |
| Total
stockholders’ equity | |
| 535,559 | | |
| 153,506 | |
| Total
liabilities and stockholders' equity | |
$ | 567,348 | | |
$ | 163,182 | |
Cypherpunk
Technologies Inc.
Consolidated
Statements of Operations
(in
thousands, except share and per share amounts)
| | |
(Unaudited) | | |
(Unaudited) | |
| | |
Three
Months Ended September 30, | | |
Nine
Months Ended September 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Mining
revenue | |
$ | 9,913 | | |
$ | - | | |
$ | 9,913 | | |
$ | - | |
| | |
| | | |
| | | |
| | | |
| | |
| Operating
costs and expenses: | |
| | | |
| | | |
| | | |
| | |
| Cost
of revenue (excluding depreciation and amortization) | |
| 936 | | |
| - | | |
| 936 | | |
| - | |
| Research
and development | |
| 233 | | |
| 1,247 | | |
| 591 | | |
| 24,695 | |
| General
and administrative | |
| 4,944 | | |
| 1,919 | | |
| 14,092 | | |
| 6,742 | |
| Depreciation
and amortization | |
| 1,194 | | |
| - | | |
| 1,194 | | |
| - | |
| Restructuring
charges | |
| - | | |
| - | | |
| - | | |
| 4,527 | |
| Total
operating costs and expenses | |
| 7,307 | | |
| 3,166 | | |
| 16,813 | | |
| 35,964 | |
| Income
(loss) from operations | |
| 2,606 | | |
| (3,166 | ) | |
| (6,900 | ) | |
| (35,964 | ) |
| Interest
income | |
| 59 | | |
| 123 | | |
| 217 | | |
| 806 | |
| Interest
expense | |
| (2 | ) | |
| (10 | ) | |
| (15 | ) | |
| (23 | ) |
| Australian
research and development incentives | |
| - | | |
| (56 | ) | |
| - | | |
| - | |
| Change
in fair value of embedded derivative | |
| 330,846 | | |
| - | | |
| 299,284 | | |
| - | |
| Foreign
currency gains | |
| - | | |
| 8 | | |
| 1 | | |
| 2 | |
| Income
(loss) before income taxes | |
| 333,509 | | |
| (3,101 | ) | |
| 292,587 | | |
| (35,179 | ) |
| Provision
for income taxes | |
| (27,504 | ) | |
| (202 | ) | |
| (24,359 | ) | |
| - | |
| Net
income (loss) attributable to common stockholders | |
$ | 306,005 | | |
$ | (3,303 | ) | |
$ | 268,228 | | |
$ | (35,179 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Net
income (loss) per share | |
| | | |
| | | |
| | | |
| | |
| Basic | |
$ | 1.44 | | |
$ | (0.08 | ) | |
$ | 1.42 | | |
$ | (0.85 | ) |
| Diluted | |
$ | 1.13 | | |
$ | (0.08 | ) | |
$ | 1.17 | | |
$ | (0.85 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Weighted
average common shares outstanding | |
| | | |
| | | |
| | | |
| | |
| Basic | |
| 212,440,711 | | |
| 41,444,979 | | |
| 188,453,303 | | |
| 41,386,929 | |
| Diluted | |
| 271,933,041 | | |
| 41,444,979 | | |
| 230,134,265 | | |
| 41,386,929 | |
Leap
Therapeutics, Inc.
Condensed
Consolidated Statements of Cash Flows
(in
thousands)
| | |
(Unaudited) | | |
(Unaudited) | |
| | |
Three
Months Ended September 30, | | |
Nine
Months Ended September 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Cash
used in operating activities | |
$ | (2,902 | ) | |
$ | (8,317 | ) | |
$ | (9,024 | ) | |
$ | (37,283 | ) |
| Cash
used in investing activities | |
| (6,000 | ) | |
| - | | |
| (24,544 | ) | |
| - | |
| Cash
provided by (used in) financing activities | |
| 57,259 | | |
| (121 | ) | |
| 75,501 | | |
| (301 | ) |
| Effect
of exchange rate changes on cash and cash equivalents | |
| 7 | | |
| (6 | ) | |
| 20 | | |
| 21 | |
| Net
increase (decrease) in cash and cash equivalents | |
| 48,364 | | |
| (8,444 | ) | |
| 41,953 | | |
| (37,563 | ) |
| Cash
and cash equivalents at beginning of period | |
| 7,624 | | |
| 18,130 | | |
| 14,035 | | |
| 47,249 | |
| Cash
and cash equivalents at end of period | |
$ | 55,988 | | |
$ | 9,686 | | |
$ | 55,988 | | |
$ | 9,686 | |
CONTACT:
Douglas E. Onsi
President & Chief Executive Officer
Cypherpunk Technologies Inc.
617-714-0360
For Media:
Jacqueline Ortiz Ramsay
Head of Communications
954-294-3249
jacqueline@cypherpunk.com
For Investors:
Matthew DeYoung
Investor Relations
Argot Partners
212-600-1902
leap@argotpartners.com